Editorial: Human Milk, Nutrition and Infant Development, Volume II

Why It Matters

Human milk’s unparalleled biological activity directly impacts infant morbidity, cognitive outcomes, and long‑term metabolic health, making it a critical focus for healthcare policy and the infant‑nutrition market.

Key Takeaways

• Human milk outperforms formula in nutrients and bioactives.
• DHA and NA levels link to cognitive development.
• Fortified donor milk reduces necrotizing enterocolitis.
• HMOs shape gut microbiome and immune tolerance.
• Innovative processing (HHP) preserves milk bioactivity.

Pulse Analysis

Human milk’s composition is a moving target, adapting to an infant’s developmental stage through precise shifts in proteins, lipids, and micronutrients. Researchers now map how lactoferrin, α‑lactalbumin, and long‑chain polyunsaturated fatty acids such as DHA and ARA support cellular growth, retinal maturation, and synaptic plasticity. The presence of nervonic acid in early colostrum further fuels myelination, giving preterm infants a measurable advantage over formula‑fed peers. These insights are reshaping infant‑nutrition strategies, prompting formula manufacturers to incorporate milk‑fat‑globule membrane and targeted fatty‑acid blends, yet the biological complexity of native milk remains unmatched.

Beyond calories, human milk operates as an immunological platform. Human milk oligosaccharides act as prebiotic scaffolds that nurture Bifidobacterium species while simultaneously blocking pathogen adhesion. Coupled with cytokines, secretory IgA, and exosomal microRNAs, these components orchestrate mucosal defense and modulate systemic immune tolerance. Emerging evidence links HM‑derived short‑chain fatty acids to the gut‑brain axis, influencing neurotransmitter synthesis and stress resilience. Epigenetic regulators in milk, particularly microRNA‑mediated Wnt signaling, may lower lifelong risks of type‑2 diabetes and metabolic syndrome, positioning breastfeeding as a preventive health intervention.

Practical barriers—maternal pain, stress‑induced cortisol spikes, and limited access to donor milk—remain significant. Innovations such as osteopathic manipulative therapy and mental‑health support aim to boost breastfeeding rates, while high‑hydrostatic‑pressure (HHP) processing preserves over 95% of bioactive compounds in donor milk, outperforming traditional Holder pasteurization. Multi‑omics cohort studies, especially those tracking preterm infants in China, are unveiling how subtle variations in milk composition intersect with gut microecology to affect outcomes. Policymakers and clinicians can leverage this data to refine fortification protocols, prioritize safe milk‑bank practices, and ultimately close the gap between the biological ideal of human milk and the realities of modern infant care.